Effects Of Detrol LA On Memory And Cognition In Elderly Population

Completed · Phase 4

Conditions studied: Memory, Cognition

In brief

The primary purpose of the trial is to show that tolterodine ER has no effect on memory and other cognitive abilities in an elderly population

Key facts

Study ID

NCT00411437

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

220

Starts

2006-12-01

Expected to finish

2007-06-01

Last updated by the study team

2021-01-27

Who can join

Age: 65 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female subjects with age of 65 - 75 years
• Having a score of greater than or equal to 26 on the Mini-Mental State Exam (MMSE)

You may not qualify if…

• Current or history of bladder outlet obstruction. Previous history of acute urinary retention requiring catheterization, or severe voiding difficulties in the judgment of the investigator, prior to randomization
• Significant hepatic or renal disease, defined as twice the upper limit of the reference ranges regarding serum concentrations of AST, ALT, ALP, urea nitrogen, or creatinine

Where it is running

• Pfizer Investigational Site — Tucson, Arizona, United States
• Pfizer Investigational Site — Brooksville, Florida, United States
• Pfizer Investigational Site — DeLand, Florida, United States
• Pfizer Investigational Site — Naples, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — St. Petersburg, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — West Palm Beach, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.